DEA Archived Press Releases

Press Releases before January 20, 2025
6 Results - Showing 1 to 6
PRESS RELEASE

Indictment Charges Alleged Darknet Marketplace Fentanyl Dealer

WASHINGTON – An indictment, unsealed today, charges a Coraopolis, Pennsylvania man with running a counterfeit drug conspiracy that sold fentanyl and methamphetamine disguised as Oxycontin, Xanax and Adderall on a Darknet Marketplace. Jacob Blair, 25, is also charged in a parallel indictment in the Western District of Pennsylvania with possession...
PRESS RELEASE

25th Operation High Tide Defendant Sentenced for Drug and Gun Crimes

NORFOLK, Va. – A Portsmouth man, who was the 25th defendant associated with Operation High Tide, was sentenced today for his role in trafficking firearms and selling heroin. According to court documents, in 2017, Shon E. Melton, 32, of Portsmouth, was attributed with trafficking 19 firearms, including a concealable short...
PRESS RELEASE

Chinese national pleads guilty for failing to report foreign national bank account

CHARLOTTE, N.C. – Lili Bian, a 59-year old citizen of China and a lawful permanent resident of the United States living in Charlotte, appeared in federal court today and pleaded guilty to failing to report a foreign bank account with a balance exceeding $10,000, announced U.S. Attorney for the Western...
PRESS RELEASE

DEA acts against dangerous, deadly designer synthetic drug linked to 151 overdose deaths since 2015

WASHINGTON – The Drug Enforcement Administration today announced action against a dangerous designer synthetic cathinone linked to 151 overdose deaths in the United States between 2015 and 2018. Published in today’s Federal Register, DEA’s action puts N-Ethylpentylone into Schedule I of the Controlled Substances Act. Schedule I substances refer to...
PRESS RELEASE

DEA investigators seeking answers in small Tennessee town

CELINA, Tenn. -- DEA investigators this week conducted inspections at several pharmacy locations in the Clay County, Tennessee town of Celina, following an inquiry into irregular patterns of pill purchases from drug distribution companies. DEA is now investigating possible criminal activity involving the illicit diversion of controlled prescription pharmaceuticals at...
PRESS RELEASE

Justice Department, DEA propose significant opioid manufacturing reduction in 2019

WASHINGTON – The Department of Justice and U.S. Drug Enforcement Administration have proposed a reduction for controlled substances that may be manufactured in the U.S. next year. Consistent with President Trump’s “Safe Prescribing Plan” that seeks to “cut nationwide opioid prescription fills by one-third within three years,” the proposal decreases...